세계의 유전체학 시장 : 예측(2025-2030년)

The genomics market is expected to grow from USD 35.900 billion in 2025 to USD 62.397 billion in 2030, at a CAGR of 11.69%.

The global genomics market is experiencing robust growth, driven by the rising prevalence of diseases, particularly cancer, and increasing government and private initiatives to advance genetic research. Genomics, encompassing recombinant DNA, DNA sequencing, and bioinformatics, analyzes an organism's entire genome, supporting applications in gene therapy, personalized medicine, and clinical research. The market is propelled by the demand for innovative therapeutic solutions and collaborative efforts among industry players.

Market Drivers

Rising Disease Prevalence and Cancer Genomics

The increasing incidence of diseases, particularly inherited cancers, is a primary driver of the genomics market. The growing understanding of the human genome has spurred the development of advanced gene therapies, leveraging technologies like CRISPR-Cas for cancer treatment. The demand for cancer genomics is rising due to its potential to identify genetic variations and develop targeted therapies, enhancing treatment efficacy and patient outcomes.

Government and Private Initiatives

Significant government and private sector investments are accelerating genomics research. For instance, in December 2022, the UK Department of Health and Social Care allocated £175 million to fund genomics research, supporting a three-year plan to develop and implement cutting-edge genomic healthcare technologies. These initiatives aim to analyze patients' DNA to improve diagnostics and treatment, driving market growth. Similarly, pharmaceutical and biotechnology companies are investing heavily in drug discovery and personalized medicine, further boosting the market through innovative research and development strategies.

Collaborative Efforts and Industry Partnerships

Collaborations, joint ventures, and acquisitions among industry players are enhancing genomics market growth. These partnerships facilitate the integration of advanced technologies and expand the scope of genomic applications in diagnostics and precision medicine. The focus on collaborative research is fostering innovation, enabling the development of novel tools and platforms to address complex health challenges.

Geographical Outlook

North America

North America holds a significant share of the global genomics market, driven by its concentration of major pharmaceutical companies and research organizations. The region's robust infrastructure supports initiatives like the Human Genome Project and the Cancer Genome Atlas Program, which advance genomic applications in disease research and therapeutic development. The U.S. remains a leader due to its focus on genetic expression and its impact on health outcomes, supporting market expansion.

Asia-Pacific

The Asia-Pacific region is expected to grow at a high compound annual growth rate (CAGR), fueled by the rising prevalence of diseases and increasing demand for innovative therapeutic drugs and diagnostics. Government and private sector initiatives, such as large-scale human genome sequencing projects, are driving market growth. The region's focus on addressing health challenges through genomics, particularly in countries like China and India, positions it as a key growth hub.

Market Trends

The genomics market is characterized by the adoption of cutting-edge technologies like CRISPR-Cas for gene editing and the integration of bioinformatics for comprehensive genome analysis. The rising demand for personalized medicine and cancer genomics is driving innovation in diagnostic and therapeutic applications. Collaborative efforts, such as acquisitions and joint ventures, are enhancing the development of advanced genomic platforms. The market also benefits from increased government funding and private sector investment in precision medicine and drug discovery, aligning with global health priorities.

The genomics market is poised for significant growth, driven by the rising prevalence of diseases, particularly cancer, and robust government and private initiatives. North America leads due to its strong pharmaceutical and research ecosystem, while Asia-Pacific is set for rapid expansion with increasing demand for diagnostics and therapeutics. Trends toward advanced gene editing, collaborative partnerships, and innovative tools are shaping the market's future. As the focus on personalized medicine and genomic healthcare intensifies, the genomics market is well-positioned for sustained expansion, addressing critical health challenges during the forecast period.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Market Segmentation:

By Technology

• PCR
• Sequencing
• Microarray
• Nucleic Acid Extraction and Purification
• Others

By Application

• Drug Discovery and Development
• Diagnostics
• Precision Medicine
• Agriculture and Animal Research
• Other Applications

By End-User

• Hospitals & Clinics
• Research Centers & Government Institutes
• Pharmaceutical & Biotechnology Companies
• Others

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East And Africa
• Saudi Arabia
• Israel
• Other
• Asia Pacific
• China
• Japan
• India
• South Korea
• Indonesia
• Taiwan
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

• 2.1. Research Data
• 2.2. Sources
• 2.3. Research Design

3. EXECUTIVE SUMMARY

• 3.1. Research Highlights

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. GLOBAL GENOMICS MARKET BY APPLICATION

• 5.1. Introduction
• 5.2. Drug Discovery and Development
• 5.3. Diagnostics
• 5.4. Precision Medicine
• 5.5. Agriculture and Animal Research
• 5.6. Other Applications

6. GLOBAL GENOMICS MARKET BY END-USER

• 6.1. Introduction
• 6.2. Hospitals & clinics
• 6.3. Research centers & Government Institutes
• 6.4. Pharmaceutical & Biotechnology Companies
• 6.5. Others

7. GLOBAL GENOMICS MARKET BY TECHNOLOGY

• 7.1. Introduction
• 7.2. PCR
• 7.3. Sequencing
• 7.4. Microarray
• 7.5. Nucleic Acid Extraction and Purification
• 7.6. Others

8. GLOBAL GENOMICS MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East And Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. Israel
  • 8.5.3. Other
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. Japan
  • 8.6.3. India
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Taiwan
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Emerging Players and Market Lucrativeness
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

• 10.1. Illumina, Inc
• 10.2. Thermo Fisher Scientific, Inc
• 10.3. Qiagen
• 10.4. Bio-Rad Laboratories, Inc
• 10.5. Danaher
• 10.6. BGI Genomics
• 10.7. F. Hoffmann-La Roche
• 10.8. Merck KGaA
• 10.9. Integrated DNA Technologies, Inc.
• 10.10. Agilent Technologies, Inc.